338 related articles for article (PubMed ID: 31738791)
1. Cyclosporine A eyedrops with self-nanoemulsifying drug delivery systems have improved physicochemical properties and efficacy against dry eye disease in a murine dry eye model.
Bang SP; Yeon CY; Adhikari N; Neupane S; Kim H; Lee DC; Son MJ; Lee HG; Kim JY; Jun JH
PLoS One; 2019; 14(11):e0224805. PubMed ID: 31738791
[TBL] [Abstract][Full Text] [Related]
2. Cyclosporine Amicellar delivery system for dry eyes.
Kang H; Cha KH; Cho W; Park J; Park HJ; Sun BK; Hyun SM; Hwang SJ
Int J Nanomedicine; 2016; 11():2921-33. PubMed ID: 27382280
[TBL] [Abstract][Full Text] [Related]
3. The Efficiency of Cyclosporine A-Eluting Contact Lenses for the Treatment of Dry Eye.
Choi JH; Li Y; Jin R; Shrestha T; Choi JS; Lee WJ; Moon MJ; Ju HT; Choi W; Yoon KC
Curr Eye Res; 2019 May; 44(5):486-496. PubMed ID: 30580651
[TBL] [Abstract][Full Text] [Related]
4. Topical cyclosporine inhibits conjunctival epithelial apoptosis in experimental murine keratoconjunctivitis sicca.
Strong B; Farley W; Stern ME; Pflugfelder SC
Cornea; 2005 Jan; 24(1):80-5. PubMed ID: 15604871
[TBL] [Abstract][Full Text] [Related]
5. Goblet cell numbers and epithelial proliferation in the conjunctiva of patients with dry eye syndrome treated with cyclosporine.
Kunert KS; Tisdale AS; Gipson IK
Arch Ophthalmol; 2002 Mar; 120(3):330-7. PubMed ID: 11879137
[TBL] [Abstract][Full Text] [Related]
6. Modulation of Inflammation-Related Genes in the Cornea of a Mouse Model of Dry Eye upon Treatment with Cyclosporine Eye Drops.
Daull P; Barabino S; Feraille L; Kessal K; Docquier M; Parsadaniantz SM; Baudouin C; Garrigue JS
Curr Eye Res; 2019 May; 44(5):476-485. PubMed ID: 30664361
[TBL] [Abstract][Full Text] [Related]
7. Effects of sequential artificial tear and cyclosporine emulsion therapy on conjunctival goblet cell density and transforming growth factor-beta2 production.
Pflugfelder SC; De Paiva CS; Villarreal AL; Stern ME
Cornea; 2008 Jan; 27(1):64-9. PubMed ID: 18245969
[TBL] [Abstract][Full Text] [Related]
8. Short term effects of topical cyclosporine and viscoelastic on the ocular surfaces in patients with dry eye.
Moon JW; Lee HJ; Shin KC; Wee WR; Lee JH; Kim MK
Korean J Ophthalmol; 2007 Dec; 21(4):189-94. PubMed ID: 18063881
[TBL] [Abstract][Full Text] [Related]
9. [The protection of hydrogen-rich saline on a rat dry eye model induced by scopolamine hydrobromide].
Chu YY; Hua N; Ru YS; Zhao SZ
Zhonghua Yan Ke Za Zhi; 2017 May; 53(5):363-372. PubMed ID: 28494565
[No Abstract] [Full Text] [Related]
10. RGN-259 (thymosin β4) improves clinically important dry eye efficacies in comparison with prescription drugs in a dry eye model.
Kim CE; Kleinman HK; Sosne G; Ousler GW; Kim K; Kang S; Yang J
Sci Rep; 2018 Jul; 8(1):10500. PubMed ID: 30002412
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of the mineral oil and hyaluronic acid mixture eye drops in murine dry eye.
Choi JH; Kim JH; Li Z; Oh HJ; Ahn KY; Yoon KC
Korean J Ophthalmol; 2015 Apr; 29(2):131-7. PubMed ID: 25829831
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic effects of epidermal growth factor on benzalkonium chloride-induced dry eye in a mouse model.
Xiao X; He H; Lin Z; Luo P; He H; Zhou T; Zhou Y; Liu Z
Invest Ophthalmol Vis Sci; 2012 Jan; 53(1):191-7. PubMed ID: 22159022
[TBL] [Abstract][Full Text] [Related]
13. Effects of topical cyclosporine a plus artificial tears versus artificial tears treatment on conjunctival goblet cell density in dysfunctional tear syndrome.
Demiryay E; Yaylali V; Cetin EN; Yildirim C
Eye Contact Lens; 2011 Sep; 37(5):312-5. PubMed ID: 21792057
[TBL] [Abstract][Full Text] [Related]
14. One-Year Efficacy and Safety of 0.1% Cyclosporine a Cationic Emulsion in the Treatment of Severe Dry Eye Disease.
Baudouin C; de la Maza MS; Amrane M; Garrigue JS; Ismail D; Figueiredo FC; Leonardi A
Eur J Ophthalmol; 2017 Nov; 27(6):678-685. PubMed ID: 28708219
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Effects of STAT3 Inhibition on Experimental Murine Dry Eye.
Qu M; Qi X; Wang Q; Wan L; Li J; Li W; Li Y; Zhou Q
Invest Ophthalmol Vis Sci; 2019 Sep; 60(12):3776-3785. PubMed ID: 31503282
[TBL] [Abstract][Full Text] [Related]
16. Comparison of 0.025% FK-506, 0.05% Cyclosporin A, and 0.3% Sodium Hyaluronate Eye Drops for the Treatment of Botulinum Toxin B-Induced Mouse Dry Eye.
Lin BW; Huang WL; Wang L; Chen ZM
J Ocul Pharmacol Ther; 2018 Nov; 34(9):633-641. PubMed ID: 30227093
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of a new topical cationic emulsion of cyclosporine A on dry eye clinical signs in an experimental mouse model of dry eye.
Daull P; Feraille L; Barabino S; Cimbolini N; Antonelli S; Mauro V; Garrigue JS
Exp Eye Res; 2016 Dec; 153():159-164. PubMed ID: 27777121
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporine inhibits apoptosis in experimental murine xerophthalamia conjunctival epithelium.
Sun J; Wang J
J Huazhong Univ Sci Technolog Med Sci; 2006; 26(4):469-71. PubMed ID: 17120751
[TBL] [Abstract][Full Text] [Related]
19. Effects of silk fibroin in murine dry eye.
Kim CE; Lee JH; Yeon YK; Park CH; Yang J
Sci Rep; 2017 Mar; 7():44364. PubMed ID: 28281688
[TBL] [Abstract][Full Text] [Related]
20. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group.
Sall K; Stevenson OD; Mundorf TK; Reis BL
Ophthalmology; 2000 Apr; 107(4):631-9. PubMed ID: 10768324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
